IL6 and major depressive disorder: Higher circulating IL-6 levels are associated with schizophrenia and depression in cross-sectional (Goldsmith et al., 2016) and longitudinal (Khandaker et al., 2014; Lamers et al., 2019) studies, and are associated with treatment resistance (Lin et al., 1998; Maes et al., 1997).